Acoustic ultrasound · sensitive-skin and post-laser recovery

LDM Ultrasound

LDM delivers non-thermal acoustic ultrasound at rapidly alternating dual (3 / 10 MHz) or triple frequencies — mechanical micromassage at the cellular scale, no thermal heat, no anesthesia, no downtime. Used as a gentle adjunct for sensitive skin recovery, post-laser comfort, and rosacea-prone skin already on first-line topical care. Comfort modality with modest published evidence. NOT a rosacea cure and NOT a replacement for topical pharmacotherapy.

Board-Certified

Dermatologist

AAD International Fellow

IFAAD

FDA-cleared

Where applicable

MFDS-registered

Korean MoH&W

Reviewed personally by Dr. SangYoul Yun

Board-certified Dermatologist · AAD International Fellow (IFAAD) · IFAAD-verified

Overview

LDM (Local Dynamic Micromassage) in Gangnam — athermal acoustic ultrasound as a gentle comfort and recovery adjunct after laser, peel, or microneedling.

Best for

Rosacea diffuse erythema / flushing — athermal adjunct to first-line topical care, not a replacement
Sensitive skin barrier maintenance between laser / peel cycles
Post-laser recovery adjunct (24-72h after fractional / vascular laser)
Post-microneedling / RF microneedling recovery
Post-rhinoseptoplasty edema — strongest published indication (Ahn 2023)
Comfort modality preference — relaxing in-office session, no thermal heat
Patients researching 'German lightwave'-style devices — LDM is acoustic ultrasound, NOT light

Suited for

Adults 19+. Most patients 25-65 across all FST.
Post-procedure adjunct seekers (24-72h after laser / peel / microneedling)
FST V-VI patients — LDM is athermal and chromophore-independent (no PIH risk)
Single-session 3-day trip fits; 4-8 weekly course is NOT single-trip
Patients accepting LDM as comfort-and-recovery adjunct, not therapeutic primary
Patients accepting limited-evidence framing (1 independent RCT only)
Patients accepting regulatory disclosure — CE-marked NOT FDA-cleared; MFDS inferred
Multi-language consultation available; female staff on request.

Duration

Consultation 30 min

LDM handpiece pass 20-30 min

Total session 45-60 min including cleansing and post-cooling

Sessions

Single session for comfort or recovery adjunct

Optional 4-8 weekly course for cumulative subjective effect (NOT single-trip viable)

Post-rhinoseptoplasty edema course per Ahn 2023 protocol

Downtime

None — athermal, non-injurious, make-up same day, return to normal activity immediately

Paired laser / peel / microneedling downtime per the paired procedure

Peak result

Subjective comfort and glow Day 0

Possible cumulative subjective improvement across 4-6 weekly sessions (no objective TEWL or barrier function RCT)

Post-rhinoseptoplasty edema reduction signal per Ahn 2023 through 3-8 week surgical recovery window

Timeline

Day 0
Warm-water-feel sensation during session. Mild transient flush at most. Makeup OK same day; no downtime. Subjective 'glow' frequently reported.
24-72 hours
Transient flush resolves. No inflammation or peeling. Paired procedure's recovery profile dominates if applicable.
End of 4-6 weekly course
Patient-reported subjective improvement in comfort / hydration / 'glow'. Objective TEWL or barrier function improvement is NOT confirmed by independent RCT.
Realistic ceiling
Comfort and recovery adjunct. NOT a cure for rosacea / scars / pigment / anti-aging. Patients seeking those outcomes are routed to evidence-based first-line modalities.

Devices

Wellcomet LDM-MED / LDM-Triple

Wellcomet GmbH (Karlsruhe, Germany)CE-marked under EU MDR Class IIa. NOT FDA-cleared — manufacturer does not market in US. MFDS inferred via Wellcomet Asia Seoul. No specialty society consensus paper.

Key specs

: Non-thermal mechanical acoustic ultrasound (NOT light, NOT thermal)
: Dual 3 / 10 MHz (LDM-MED) or triple frequency (LDM-Triple) with rapid internal switching
Mechanism: mechanical micromassage at cellular scale
Strongest published indication: post-rhinoseptoplasty edema (Ahn 2023)
: No published RCT for rosacea / barrier / post-laser specifically
: Athermal, chromophore-independent — no PIH risk, no anesthesia, no downtime
: Propylene glycol coupling-gel sensitivity is the main adverse event

Process

01
Consultation. Rosacea: subtype, baseline topical / oral regimen, trigger profile. Non-rosacea: prior procedure history, sensitive-skin baseline. LDM = comfort adjunct only.
02
Cleansing + coupling-gel application; propylene glycol sensitivity screened.
03
LDM handpiece pass 20-30 min — smooth overlapping circular motion. Internal dual (3/10 MHz) or triple (1/3/10 + 3/10/19 MHz) frequency switching. Warm-water-feel sensation; no anesthesia.
04
Gel removed; no bandage, no downtime, makeup OK same day. 4-8 weekly sessions if cumulative course elected.

“Injectables and energy devices are performed by physicians — never delegated to non-physician staff. The clinic is led by a board-certified dermatologist.”
— Dr. SangYoul Yun · Clinic Director · Board-Certified Dermatologist · AAD IFAAD

Aftercare

Day 0
No specific LDM aftercare. Follow paired procedure's aftercare if applicable. Makeup OK same day. Continue rosacea topicals without pause.
Day 1-7
Continue baseline skincare. Monitor for delayed propylene glycol allergic contact dermatitis (24-72h post-session — erythematous plaque / pruritus). Report new persistent redness / pruritus / vesiculation.
Weeks 2-8
Maintain weekly course cadence if elected. Photo documentation at sessions 1, 4, 8. Honest session-4 check-in: discontinue if no benefit. Rosacea patients continue topical pharmacotherapy throughout.
Month 2-6
Continue baseline topical pharmacotherapy indefinitely for rosacea. No LDM maintenance is required beyond an acute course.
Long-term
No evidence base for long-term LDM. We do NOT pre-sell open-ended subscriptions. Rosacea: lifelong topical pharmacotherapy + trigger management is the chronic-disease standard.

FAQ

Is LDM FDA-approved?

No. Wellcomet LDM is CE-marked Class IIa, NOT FDA-cleared. Manufacturer does not market the platform in the US. MFDS inferred via the Wellcomet Asia Seoul subsidiary. 'FDA-approved' or 'TÜV-certified' marketing is factually incorrect.

Does LDM cure rosacea?

No. Rosacea is chronic relapsing — no modality cures it. First-line per ROSCO consensus: topical metronidazole / ivermectin / azelaic + brimonidine + PDL/IPL + oral doxycycline. LDM is comfort adjunct on top of established care. We refuse to start LDM for rosacea patients who have not been offered first-line care.

What is the LDM evidence base?

Sparse. PubMed-indexed: one independent Korean RCT in post-rhinoseptoplasty edema (Ahn 2023), one independent in-vitro fibroblast study (Hormozi Moghaddam 2025), two manufacturer-affiliated case series (cellulite and acne). No RCT for rosacea / barrier / post-laser / melasma / anti-aging. Specialty societies have not published an LDM consensus paper.

LDM vs HIFU (Ultherapy) or RF (Thermage)?

Fundamentally different. HIFU and monopolar RF are THERMAL modalities that produce visible lifting and tightening with substantial RCT evidence bases. LDM is NON-THERMAL acoustic ultrasound — no lifting / tightening signal, comfort and recovery adjunct only. Not interchangeable.

Can I complete an LDM course in one Seoul trip?

Single session yes, full 4-8 weekly course no. Realistic structure: 1-2 sessions in Seoul + home-country continuation. We do not recommend a single-purpose LDM trip — the cost / evidence ratio is poor vs flagship procedures.

Why is LDM safer for FST V-VI?

Athermal and chromophore-independent — does not target melanin / hemoglobin / water. No PIH pathway, no thermal burn risk. Real safety advantage in a comfort-modality role, but does NOT make LDM a substitute for evidence-based first-line care.

Can LDM replace my rosacea topical medication?

No. First-line topical pharmacotherapy has decades of RCT evidence addressing the inflammatory and microbial pathobiology of rosacea. LDM has no rosacea-specific RCT. We refuse this framing.

Most serious risk?

Allergic contact dermatitis to coupling gel (propylene glycol most common trigger). LDM itself is athermal and non-injurious. Beyond contact dermatitis, the bigger risk is misclassification — using LDM as a substitute for first-line care that delays effective treatment.

Is LDM the same as 'German lightwave' devices?

Same device, technically incorrect Korean nickname. LDM is acoustic ultrasound, NOT light. Light-based modalities (IPL, BBL, LED) work via different mechanisms — patients expecting 'light therapy' benefits will be disappointed.

LDM vs spa sonophoresis?

LDM is medical-device-grade Class IIa with rapid frequency switching, operated by credentialed clinician. Spa sonophoresis is single-frequency aesthetician-grade. Different device class, but clinical evidence delta is modest and comfort-modality scope similar.

TEWL / barrier improvement claims?

Manufacturer hypothesis, NOT confirmed by independent RCT. Plausible at the bench level, but no clinical RCT demonstrates TEWL improvement or barrier function recovery in human subjects. We do not market mechanism claims as established benefits.

Pricing in Seoul?

Korean market: single session ~₩49,000-₩170,000 (chain to clinician-delivered); 10-pack ~₩450,000-₩900,000. We do NOT pre-sell open-ended subscriptions. Per-session quote at consult.

Notice

Tell the dermatologist at consultation if any of the following apply.

Pregnancy or breastfeeding
Pacemaker, ICD, deep brain stimulator, or active electrical implant
Active skin infection, HSV, or open wound at the site
Active skin malignancy or melanoma history at the site
Hypersensitivity to coupling gel (propylene glycol — screened at consult)
Recent HA filler within 2 weeks at the site — sequenced at consultation

For your visit

3-day itinerary: one LDM session fits as a comfort adjunct 24-72h after a paired procedure. Full 4-8 weekly course is NOT single-trip.
Multi-trip cadence: trip 1 sessions 1-2, continue with home dermatologist. Single-purpose LDM trip is not recommended — the cost / evidence ratio is poor vs flagship procedures.
Written quote pre-flight on request.
Multi-language consultation available; clinic in Gangnam.
Discharge packet: device model, frequency mode, session count, gel composition, photos + English clinical summary with Dr. Yun's stamp.

References

The clinical claims on this page — device specs, efficacy timelines, safety profile — are supported by the primary sources below. Each citation links to the original paper or regulatory record.10 refs

[1]LDM dual-frequency ultrasound accelerates post-rhinoseptoplasty edema reduction — Korean RCT (single independent LDM RCT in PubMed). Aesthetic Plast Surg (Ahn — Wellcomet co-author disclosure) (2023).
[2]LDM in-vitro fibroblast viability and Type I collagen induction — independent mechanistic evidence. Lasers Med Sci (Hormozi Moghaddam) (2025).
[3]ROSCO global rosacea consensus — phenotype-based treatment recommendations (first-line topical and laser). Br J Dermatol (Schaller — ROSCO Consensus) (2020).
[4]Updated ROSCO recommendations for the management of rosacea — phenotype-based algorithm. Br J Dermatol (Schaller — ROSCO Consensus) (2017).
[5]Standard classification and pathophysiology of rosacea — National Rosacea Society Expert Committee. J Am Acad Dermatol (Gallo NRS Expert Committee) (2018).
[6]Standard grading system for rosacea — National Rosacea Society Expert Committee phenotype framework. J Am Acad Dermatol (Tan NRS Expert Committee) (2018).
[7]Caveolin-1 (CAV1) mechanotransduction in skin — biological substrate for non-thermal mechanical ultrasound. Int J Biochem Cell Biol (Kruglikov) (2014).
[8]Non-thermal mechanical ultrasound effects on connective tissue — mechanistic review (manufacturer-affiliated narrative). J Cosmet Dermatol (Kruglikov) (2015).
[9]Pulsed dye laser for facial telangiectasia and rosacea erythema — evidence base for first-line vascular targeting. Lasers Surg Med (Tan) (2018).
[10]Intense pulsed light vs pulsed dye laser for rosacea — comparative review. Lasers Med Sci (Husein-ElAhmed) (2017).

Reviewed byDr. SangYoul Yun· Board-Certified Dermatologist · AAD International Fellow (IFAAD) · ASLMS Member · Former Director, Banobagi Dermatology · KHIDI-registered International Patient Institution· Last reviewed 2026-05-16

Related procedures

ProcedurePRP Therapy in Seoul | Platelet-Rich Plasma Skin RejuvenationPRP therapy in Seoul uses concentrated growth factors from your own blood to stimulate collagen, repair tissue, and improve skin quality naturally.

ProcedureVbeam Perfecta Seoul | Pulsed-Dye Laser for Rosacea & RednessCandela Vbeam Perfecta 595nm pulsed-dye laser in Gangnam — for rosacea, facial redness, post-acne pink marks, and telangiectasia. Tuned for Asian skin.

Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.

Next Step

Laser and pigment results depend on your skin type — a short message (a photo helps) tells us whether LDM Ultrasound is the right protocol for you.

Even a short first message can help you check suitability, timing, and what to compare next before you book.

Contact

WhatsApp LINE KakaoTalk